The pREBOA-PROTM catheter is the world's first and only device specifically designed for prolonged aortic occlusion, a key ...

Reports $709 million in preliminary1 full-year 2024 U.S. net product revenues$611 million in SYFOVRE® U.S. net product revenues, including $167 ...

Conduction disturbance may be presented in anterior myocardial infarction due to defected blood supply from septal branch. RBBB (usually with LAFB) is one of the frequent presentations of LMCA ...

A scientific statement regarding the management of patients with stroke in rural settings with lower resources has been published by the AHA.

Pharmaceuticals announced it will share corporate progress and highlights from the company’s investigational pipeline while ...

This important study conducted experiments to quantify how changes in blood flow results in apparent fluorescence changes when imaging neural activity sensors using two-photon microscopy. While the ...

The Tom Bereznicki Charitable Educational Foundation discusses the Introduction to Occlusion Symposium, helping dentists ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm diameter-balloon; guidewire-free) Distal Intended for temporary occlusion of large vessels ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 35.6% in the past six months compared with the industry’s decline ...

amc.uva.nl Introduction Acute ischemic stroke (AIS) due to internal carotid artery (ICA) occlusion has a poor prognosis if treated by intravenous thrombolysis. Intra-arterial (IA) treatment is a ...

Fluid challenge and balloon occlusion may unmask LV disease and post-capillary pulmonary hypertension, but their role in the evaluation of patients with ‘operable’ ASDs is not well established.

NVIDIA files a patent for AI glasses, could enter the AR glasses market alongside Apple, Meta and others sometime in 2025...